NCT03804229 - Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia | Biotech Hunter

Enrollment

707

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

October 23, 2024

Study Completion Date

February 7, 2025

Conditions

Vascular Dementia

Interventions

DRUG

Butylphthalide soft capsule

700 subjects are randomly divided into two groups by 1:1. About 350 patients in the active group take two pills(100mg each) of Butylphthalide soft capsule each time, three times a day, 0.5 hours before meal, taking with lukewarm water.

DRUG

Placebo soft capsule

700 subjects are randomly divided into two groups by 1:1. About 350 patients in the active group take two pills of placebo soft capsule each time, three times a day, 0.5 hours before meal, taking with lukewarm water.

Trial Locations (1)

100053

Xuanwu Hospital of Capital Medical University, Beijing